We found a significant difference between the two groups where the group showing a higher CD4 T-cell IFNγ expression had a lower tumor burden (responders) and the group with a lower CD4 T-cell IFNγ expression had a higher tumor burden (non-responders). This evidence concerns the gene CD4 and neoplasm.